Processing

Please wait...

Settings

Settings

Goto Application

1. WO1997029111 - NEW CEPHEM COMPOUNDS AND PHARMACEUTICAL USE THEREOF

Publication Number WO/1997/029111
Publication Date 14.08.1997
International Application No. PCT/JP1997/000280
International Filing Date 05.02.1997
Chapter 2 Demand Filed 12.08.1997
IPC
A61K 31/546 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
54having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame
542ortho- or peri-condensed with heterocyclic ring systems
545Compounds containing 5-thia-1-azabicyclo octane ring systems, i.e. compounds containing a ring system of the formula , e.g. cephalosporins, cefaclor, cephalexine
546containing further heterocyclic rings, e.g. cephalothin
C07D 501/00 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
501Heterocyclic compounds containing 5-thia-1-azabicyclo octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
CPC
A61K 31/546
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
54having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
542ortho- or peri-condensed with heterocyclic ring systems
545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. cephalosporins, ; cefaclor, or cephalexine
546containing further heterocyclic rings, e.g. cephalothin
A61P 31/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
A61P 31/04
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
04Antibacterial agents
C07D 501/00
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
501Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
Applicants
  • FUJISAWA PHARMACEUTICAL CO., LTD. [JP]/[JP] (AllExceptUS)
  • YOSHIDA, Yoshiki [JP]/[JP] (UsOnly)
  • OKUDA, Shinya [JP]/[JP] (UsOnly)
  • SASAKI, Hiroshi [JP]/[JP] (UsOnly)
  • MATSUDA, Keiji [JP]/[JP] (UsOnly)
  • TAKASUGI, Hisashi [JP]/[JP] (UsOnly)
Inventors
  • YOSHIDA, Yoshiki
  • OKUDA, Shinya
  • SASAKI, Hiroshi
  • MATSUDA, Keiji
  • TAKASUGI, Hisashi
Agents
  • SEKI, Hideo
Priority Data
PN 801112.02.1996AU
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) NEW CEPHEM COMPOUNDS AND PHARMACEUTICAL USE THEREOF
(FR) NOUVEAUX COMPOSES DE CEPHEM ET LEUR UTILISATION PHARMACEUTIQUE
Abstract
(EN)
This invention relates to new cephem compounds represented by general formula (I) wherein each symbol is as defined in the specification or a salt thereof, which has antimicrobial activity against $i(Helicobacter pylori), and are useful as anti-$i(Helicobacter pylori) agents, anti-gastritis agents, anti-ulcer agents and anti-cancer agents.
(FR)
Cette invention concerne un nouveau composé de céphem représenté par la formule générale (I) dans laquelle chaque symbole est tel que défini dans la description. Cette invention concerne également les sels de ce composé, lequel possède une activité antimicrobienne dirigée contre l'$i(Helicobacter pylori). Ce composé est utile en qualité d'agent de lutte contre l'$i(Helicobacter pylori), les gastrites, les ulcères et le cancer.
Latest bibliographic data on file with the International Bureau